These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 21158658
1. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, Yu R, Zhangzhu J, Liu W, Zeng Y, Li X, Zhang X, Pang X, Deng Y. N Engl J Med; 2010 Dec 16; 363(25):2416-23. PubMed ID: 21158658 [Abstract] [Full Text] [Related]
2. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Jun 04; 59(21):657-61. PubMed ID: 20520590 [Abstract] [Full Text] [Related]
10. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M, Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain. Vaccine; 2010 Nov 03; 28(47):7460-7. PubMed ID: 20875486 [Abstract] [Full Text] [Related]
12. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N, H1N1 Working Group of Federal Immunization Safety Task Force. Pediatrics; 2011 May 03; 127 Suppl 1():S78-86. PubMed ID: 21502251 [Abstract] [Full Text] [Related]
13. Pandemic influenza. Europe reconsiders H1N1 flu shots for children. Enserink M. Science; 2009 Nov 13; 326(5955):922. PubMed ID: 19965485 [No Abstract] [Full Text] [Related]
14. [Analysis of adverse events following 2009 influenza A (H1N1) vaccinoprophylaxis in Beijing]. Miao L, Lu L, Wu J, Suo LD, Liu DL, Sun MP, Pang XH, Deng Y, Wang XL. Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Oct 13; 44(10):884-7. PubMed ID: 21176517 [Abstract] [Full Text] [Related]
15. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan. Huang WT, Chen WW, Yang HW, Chen WC, Chao YN, Huang YW, Chuang JH, Kuo HS. Vaccine; 2010 Oct 18; 28(44):7161-6. PubMed ID: 20804804 [Abstract] [Full Text] [Related]
16. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2009 Nov 13; 58(44):1241-5. PubMed ID: 19910912 [Abstract] [Full Text] [Related]
17. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]. Press R, Andersen O. Lakartidningen; 2009 Nov 13; 107(10):666-7. PubMed ID: 20402249 [No Abstract] [Full Text] [Related]